BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3859302)

  • 1. Immunosubversive role of PGE2 in tumor bearing mice.
    Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
    Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional modifications of thymocytes during tumor growth.
    Lombardi D; Naso G; Ottavio L; Lenti L; Mardente S; Pontieri GM
    Thymus; 1992 Feb; 19(1):13-33. PubMed ID: 1566282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
    Young MR; Knies S
    J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
    Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
    Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of PGE on the immune response in melanoma-bearing mice.
    Favalli C; Garaci E; Etheredge E; Santoro MG; Jaffe BM
    J Immunol; 1980 Aug; 125(2):897-902. PubMed ID: 7190176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of primary antibody response by protein A in tumor bearing mice.
    Zaidi SI; Singh KP; Raisuddin S; Jafri A; Saxena AK; Choudhary S; Ray PK
    Immunopharmacol Immunotoxicol; 1995 Nov; 17(4):759-73. PubMed ID: 8537611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
    Young MR; Young ME; Kim K
    Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
    Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of ethanol-induced suppression of a primary antibody response in a mouse model for binge drinking.
    Han YC; Pruett SB
    J Pharmacol Exp Ther; 1995 Nov; 275(2):950-7. PubMed ID: 7473187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of prostaglandin E2 on the immune response in mice, with special reference to anti-sperm immunity.
    Bratanov K; Tornyov A; Somlev B; Velev B
    Int J Fertil; 1986; 31(4):305-10. PubMed ID: 2878901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of exogenous prostaglandin E2 on different stages in the formation of a humoral immune response].
    Gromykhina NIu; Kozlov NA
    Biull Eksp Biol Med; 1982 Jun; 93(6):77-9. PubMed ID: 6956373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin].
    Narisawa T; Takahashi M; Masuda T; Nagasawa O; Koyama H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2496-501. PubMed ID: 3476022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of growth and metastasis of Lewis lung carcinoma in C57BL mice immunized with PGE2-bovine thyroglobulin conjugate].
    Li W
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):427-9. PubMed ID: 1576908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.